Integrated Prostate Cytomolecular Testing
A prostate-focused diagnostic service that integrates cytologic and molecular information into a structured, clinically useful report.
BioVantra is a urologic diagnostics company with a strong prostate focus, providing integrated cytomolecular testing, cancer estimation and mapping, and digital pathology and reporting support. Our goal is to deliver clearer, more clinically useful diagnostic information for urologists and other healthcare professionals involved in the diagnosis, surveillance, and treatment planning of prostate and bladder cancer.
Our work is organised around a focused set of urologic diagnostic offerings with a strong emphasis on prostate care, alongside bladder cancer detection and surveillance support. These offerings can be used on their own or together.
A prostate-focused diagnostic service that integrates cytologic and molecular information into a structured, clinically useful report.
Structured interpretation designed to clarify cancer extent, lesion distribution, and treatment-planning relevance.
A non-invasive offering that combines urine cytology and molecular analysis in a single integrated report to support bladder cancer detection and surveillance.
Digital pathology and synoptic reporting support intended to improve diagnostic clarity, consistency, and communication.
BioVantra works with the clinical professionals involved in diagnosing and treating prostate and bladder cancer. Our reports are shaped around the needs of these roles.
Primary users of our integrated prostate reports, supporting assessment, treatment planning, and ongoing patient management.
Structured estimation and mapping information is designed to complement imaging findings in prostate evaluation.
Consolidated diagnostic information to support treatment decisions and multidisciplinary discussion in prostate care.
Digital pathology and synoptic reporting support intended to fit within established diagnostic sign-out workflows.
Other healthcare professionals involved in prostate and bladder cancer diagnosis, treatment planning, and multidisciplinary care who rely on clear, structured diagnostic information to support clinical decision-making.
BioVantra’s work is guided by experienced clinical and laboratory leadership with expertise in pathology, urology, diagnostic workflow, and structured reporting. Our services are designed to support referring physicians with clear, clinically useful diagnostic information while maintaining alignment with established laboratory standards, quality systems, and physician-directed care.
We work with urology practices and clinical teams involved in the diagnosis and treatment of prostate and bladder cancer. Share a little about your setting and a member of our team will follow up.